These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 15954892)

  • 1. Pathophysiology of contrast medium-induced nephropathy.
    Persson PB; Hansell P; Liss P
    Kidney Int; 2005 Jul; 68(1):14-22. PubMed ID: 15954892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-induced nephropathy.
    Persson PB
    Eur Radiol; 2005 Nov; 15 Suppl 4():D65-9. PubMed ID: 16479650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast medium-induced nephropathy: the pathophysiology.
    Persson PB; Tepel M
    Kidney Int Suppl; 2006 Apr; (100):S8-10. PubMed ID: 16612403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-induced nephropathy: review of incidence and pathophysiology.
    Quader MA; Sawmiller C; Sumpio BA
    Ann Vasc Surg; 1998 Nov; 12(6):612-20. PubMed ID: 9841696
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality.
    Rudnick MR; Goldfarb S
    Rev Cardiovasc Med; 2003; 4 Suppl 5():S28-33. PubMed ID: 14668707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal haemodynamic alterations in contrast medium-induced nephropathy and the benefit of hydration.
    Persson PB; Patzak A
    Nephrol Dial Transplant; 2005 Feb; 20 Suppl 1():i2-5. PubMed ID: 15705945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast medium use.
    Davidson C; Stacul F; McCullough PA; Tumlin J; Adam A; Lameire N; Becker CR;
    Am J Cardiol; 2006 Sep; 98(6A):42K-58K. PubMed ID: 16949380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remote Ischemic Preconditioning To Reduce Contrast-Induced Nephropathy: A Randomized Controlled Trial.
    Menting TP; Sterenborg TB; de Waal Y; Donders R; Wever KE; Lemson MS; van der Vliet JA; Wetzels JF; SchultzeKool LJ; Warlé MC
    Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):527-32. PubMed ID: 26015372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proof of principle: hydration by low-osmolar mannitol-glucose solution alleviates undesirable renal effects of an iso-osmolar contrast medium in rats.
    Seeliger E; Ladwig M; Sargsyan L; Cantow K; Persson PB; Flemming B
    Invest Radiol; 2012 Apr; 47(4):240-6. PubMed ID: 22353855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-induced nephropathy: Basic concepts, pathophysiological implications and prevention strategies.
    Mamoulakis C; Tsarouhas K; Fragkiadoulaki I; Heretis I; Wilks MF; Spandidos DA; Tsitsimpikou C; Tsatsakis A
    Pharmacol Ther; 2017 Dec; 180():99-112. PubMed ID: 28642116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast Media-Different Types of Contrast Media, Their History, Chemical Properties, and Relative Nephrotoxicity.
    Lohani S; Rudnick MR
    Interv Cardiol Clin; 2020 Jul; 9(3):279-292. PubMed ID: 32471669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of Contrast-Induced Acute Kidney Injury.
    Bansal S; Patel RN
    Interv Cardiol Clin; 2020 Jul; 9(3):293-298. PubMed ID: 32471670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why is diabetes mellitus a risk factor for contrast-induced nephropathy?
    Heyman SN; Rosenberger C; Rosen S; Khamaisi M
    Biomed Res Int; 2013; 2013():123589. PubMed ID: 24350240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention.
    Feldkamp T; Kribben A
    Minerva Med; 2008 Apr; 99(2):177-96. PubMed ID: 18431326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotoxic effects of X-ray contrast media.
    Andrew E; Berg KJ
    J Toxicol Clin Toxicol; 2004; 42(3):325-32. PubMed ID: 15362604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
    Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential activation of signaling pathways by low-osmolar and iso-osmolar radiocontrast agents in human renal tubular cells.
    Andreucci M; Faga T; Russo D; Bertucci B; Tamburrini O; Pisani A; Sabbatini M; Fuiano G; Michael A
    J Cell Biochem; 2014 Feb; 115(2):281-9. PubMed ID: 24023012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiographic contrast nephropathy].
    Andreucci M
    G Ital Nefrol; 2014; 31(5):. PubMed ID: 25315721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is contrast medium osmolality a causal factor for contrast-induced nephropathy?
    Bucher AM; De Cecco CN; Schoepf UJ; Meinel FG; Krazinski AW; Spearman JV; McQuiston AD; Wang R; Bucher J; Vogl TJ; Katzberg RW
    Biomed Res Int; 2014; 2014():931413. PubMed ID: 24800254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the consequences of contrast-induced nephropathy.
    Nikolsky E; Mehran R
    Rev Cardiovasc Med; 2003; 4 Suppl 5():S10-8. PubMed ID: 14668705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.